2.34
0.00%
0.03
Rani Therapeutics Holdings Inc (RANI) 最新ニュース
Rani Therapeutics appoints Marcum as new auditor - Investing.com India
Rani Therapeutics appoints Marcum as new auditor By Investing.com - Investing.com Canada
Rani Therapeutics appoints Marcum as new auditor By Investing.com - Investing.com UK
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) market cap dropped US$17m last week; Retail investors bore the brunt - Simply Wall St
Rani Therapeutics to Participate in September Investor Conferences - ForexTV.com
Rani Therapeutics to Participate in September Investor Conferences - GlobeNewswire
Rani Therapeutics to Participate in September Investor Conferences - StockTitan
Vanguard Group Inc. Has $2.13 Million Holdings in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World
Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders are individual investors who were rewarded as market cap surged US$12m last week - Yahoo Finance
RANIRani Therapeutics Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Rani Therapeutics (NASDAQ:RANI) PT Lowered to $9.00 - Defense World
Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Price Target at $12.38 - MarketBeat
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Rating of “Buy” from Analysts - Defense World
Rani Therapeutics (NASDAQ:RANI) Given New $9.00 Price Target at HC Wainwright - MarketBeat
Rani Therapeutics stock target cut, rating held on Q2 results By Investing.com - Investing.com Canada
Rani Therapeutics price target lowered to $9 from $13 at H.C. Wainwright - TipRanks
FY2024 EPS Estimates for Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Lowered by Analyst - MarketBeat
Brokers Set Expectations for Rani Therapeutics Holdings, Inc.’s FY2024 Earnings (NASDAQ:RANI) - Defense World
FY2024 EPS Estimates for Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Reduced by Analyst - Defense World
How To Buy Rani Therapeutics Holdings, Inc. Stock Online in August 2024 - Traders Union
Rani Therapeutics (NASDAQ:RANI) Announces Quarterly Earnings Results - MarketBeat
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - GlobeNewswire
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - StockTitan
Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - Yahoo Finance
Rani Therapeutics (NASDAQ:RANI) Coverage Initiated at Oppenheimer - Defense World
Rani Therapeutics (NASDAQ:RANI) Receives New Coverage from Analysts at Oppenheimer - MarketBeat
Rani Therapeutics initiated with an Outperform at Oppenheimer - TipRanks
Rani Therapeutics to Participate in August Investor Conferences - GlobeNewswire
Rani Therapeutics to Participate in August Investor Conferences - StockTitan
Rani Therapeutics to Participate in August Investor Conferences - Yahoo Finance
Rani Therapeutics secures $10 million in stock sale - Investing.com India
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of “Buy” from Analysts - Defense World
Form 424B5 Rani Therapeutics Holdin - StreetInsider.com
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $12.29 Consensus Target Price from Analysts - MarketBeat
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - ForexTV.com
Rani Therapeutics secures $10 million in stock sale By Investing.com - Investing.com UK
Rani Therapeutics prices securities offering to raise $10 million - Seeking Alpha
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - GlobeNewswire
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - StockTitan
Does Rani Therapeutics Holdings (NASDAQ:RANI) Have A Healthy Balance Sheet? - Simply Wall St
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update - WICZ
Rani Therapeutics (NASDAQ:RANI) versus Cingulate (NASDAQ:CING) Critical Contrast - Defense World
Quantum Corp amends credit agreements, issues stock warrants - Investing.com
HF direct investments pool sells shares of Westrock Coffee Co for $188k By Investing.com - Investing.com India
Rani Therapeutics opts out of equity financing amid market review - Investing.com
HF direct investments pool sells shares of Westrock Coffee Co for $188k By Investing.com - Investing.com UK
Rani Therapeutics Reevaluates Equity Financing Strategy - TipRanks
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
RANI: GLP-2 Deal Announced - Research Tree
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
RANI: GLP-2 Deal Announced - Yahoo Finance
HC Wainwright Reiterates "Buy" Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat
HC Wainwright Reiterates “Buy” Rating for Rani Therapeutics (NASDAQ:RANI) - Defense World
Analyst sets price target for Digital Realty Trust shares on earnings growth By Investing.com - Investing.com
Rani, ProGen enter obesity treatment collaboration - Investing.com India
Rani Therapeutics maintains Buy rating on collaboration with ProGen By Investing.com - Investing.com Australia
Rani Therapeutics maintains Buy rating on collaboration with ProGen By Investing.com - Investing.com
Rani Therapeutics maintains Buy rating on collaboration with ProGen By Investing.com - Investing.com Canada
Rani Therapeutics maintains Buy rating on collaboration with ProGen By Investing.com - Investing.com UK
Alnylam reports positive Phase 3 results for heart drug vutrisiran By Investing.com - Investing.com
Citi maintains neutral on Agilent stock By Investing.com - Investing.com
Rani, ProGen enter obesity treatment collaboration By Investing.com - Investing.com UK
Soluna Holdings secures $12.5 million for AI data centers By Investing.com - Investing.com UK
Rani, ProGen Partner to Co-Develop & Commercialize Oral Obesity Treatment - Contract Pharma
Rani Therapeutics enters into partnership with ProGen for oral obesity treatment - Seeking Alpha
大文字化:
|
ボリューム (24 時間):